LongVCYTJun 2026
Veracyte, Inc.
Meridian owns Veracyte for durable, volume-driven genomic-testing revenue, an expanding diagnostic menu, and a competitive moat built on more than a decade of proprietary…
VCYT
Which hedge funds are long VCYT?
1 published idea on Veracyte, Inc. across 1 fund — 1 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Veracyte, Inc.: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.